PMLRARm4 transgenic mice
Mouse . | Transgene Expression in Bone Marrow . | Age at Death (days) . | Reason for Death . |
---|---|---|---|
4042 | + | 93 | Leukemia |
4048* | ++ | 37 | Abnormal Skin Growth† |
4048.2 | 189 | Leukemia | |
4048.3 | 215 | Leukemia | |
4048.4 | 259 | Leukemia | |
4048.5 | 328 | Leukemia | |
4048.6 | 341 | Abdominal Sarcoma‡ | |
4099 | ++ | 156 | Leukemia |
4100 | − | 548 | Study1-153 |
4104 | + | 235 | Leukemia |
4105 | + | 235 | Abnormal Skin Growth |
4114 | − | 235 | Abnormal Skin Growth |
Mouse . | Transgene Expression in Bone Marrow . | Age at Death (days) . | Reason for Death . |
---|---|---|---|
4042 | + | 93 | Leukemia |
4048* | ++ | 37 | Abnormal Skin Growth† |
4048.2 | 189 | Leukemia | |
4048.3 | 215 | Leukemia | |
4048.4 | 259 | Leukemia | |
4048.5 | 328 | Leukemia | |
4048.6 | 341 | Abdominal Sarcoma‡ | |
4099 | ++ | 156 | Leukemia |
4100 | − | 548 | Study1-153 |
4104 | + | 235 | Leukemia |
4105 | + | 235 | Abnormal Skin Growth |
4114 | − | 235 | Abnormal Skin Growth |
Relative levels based on visual comparison of western blots. ++: expression equal to or greater than PMLRARα expression in the highest expressing line of MRP8-PMLRARα transgenic mice (line 556). +: expression present but less than PMLRARα expression in line 556. +/−: minimal expression. −: no signal on western blot.
When nonleukemic founder 4048 was euthanized at 37 days of age, its bone marrow was transplanted into lethally irradiated nontransgenic FVB/N mice. These mice were designated as 4048.1-4048.6. Mouse 4048.1 was euthanized for assessment of transgene expression and the other 5 recipient mice were monitored for illness.
Founders 4042, 4048, 4099, 4105, and 4114 exhibited abnormal skin growth similar to that seen in our MRP8-PMLRARα transgenic mice (data not shown).
Radiation can induce sarcomas in FVB/N recipients of transgenic marrow.
This founder was euthanized at 18 months of age for examination and assessment of transgene expression.